eNauka - pregled
Pregled prema Autor Kelly, William Kevin
Prikaz rezultata 1 do 2 od 2
| Godina | Naslov | Autor(i) | Tip rezultata | Mp-kat. |
|---|---|---|---|---|
| 2019 | Clinical activity of vofatamab (V), an FGFR3 selective antibody in combination with pembrolizumab (P) in metastatic urothelial carcinoma (mUC), updated interim analysis of FIERCE-22 | Siefker-Radtke, Arlene O; Lugowska, Iwona; Tupikowski, Krzysztof; Andric, Zoran G   ; Rezazadeh-Kalebasty, A; Curigliano, Giuseppe; Vaena, Daniel A; Vogl, FD; Currie, Graeme; Abella, S;
Kelly, William Kevin;
| Konferencijski rad | Mp kategorija će biti prikazana naknadno. |
| 2019 | FIERCE-22: Clinical activity of vofatamab (V) a FGFR3 selective inhibitor in combination with pembrolizumab (P) in WT metastatic urothelial carcinoma, preliminary analysis. | Siefker-Radtke, Arlene O; Currie, Graeme; Abella, Esteban; Vaena, Daniel A; Kalebasty, Arash Rezazadeh; Curigliano, Giuseppe; Tupikowski, Krzysztof; Andric, Zoran G ; Lugowska, Iwona; Kelly, William Kevin | Konferencijski rad | Mp kategorija će biti prikazana naknadno. |